Gary Ingenito
Net Worth

Last updated:

What is Gary Ingenito net worth?

The estimated net worth of Dr. Gary Ingenito is at least $12,826,766 as of 9 Dec 2024. He owns shares worth $1,036,043 as insider, has earned $7,954,983 from insider trading and has received compensation worth at least $3,835,740 in Catalyst Pharmaceuticals, Inc..

What is the salary of Gary Ingenito?

Dr. Gary Ingenito salary is $639,290 per year as Chief Medical & Regulatory Officer in Catalyst Pharmaceuticals, Inc..

How old is Gary Ingenito?

Dr. Gary Ingenito is 69 years old, born in 1956.

What stocks does Gary Ingenito currently own?

As insider, Dr. Gary Ingenito owns shares in one company:

Company Title Shares Price per share Total value
Catalyst Pharmaceuticals, Inc. (CPRX) Chief Medical & Regulatory Officer 51,391 $20.16 $1,036,043

What does Catalyst Pharmaceuticals, Inc. do?

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

CPRX logo
CPRX
Catalyst Pharmaceuticals, Inc.
$20.16

Gary Ingenito insider trading

Catalyst Pharmaceuticals, Inc.

Dr. Gary Ingenito has made 15 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 150,000 units of CPRX stock on 4 Dec 2019. As of 9 Dec 2024 he still owns at least 51,391 units of CPRX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock, par value $0.001 per share 7,349 N/A N/A
Option
Restricted Stock Units 7,349 N/A N/A
Option
Options to purchase common stock 12,000 $4.01 $48,120
Sale
Common stock, par value $0.001 per share 8,631 $22.74 $196,269
Option
Common stock, par value $0.001 per share 12,000 $4.01 $48,120
Sale
Common stock, par value $0.001 per share 3,369 $22.67 $76,385
Option
Common stock, par value $0.001 per share 38,000 $4.01 $152,380
Option
Options to purchase common stock 38,000 $4.01 $152,380
Sale
Common stock, par value $0.001 per share 38,000 $21.2 $805,562
Sale
Common stock, par value $0.001 per share 100,000 $18.04 $1,804,000
Option
Options to purchase common stock 100,000 $4.01 $401,000
Option
Common stock, par value $0.001 per share 100,000 $4.01 $401,000
Option
Common stock, par value $0.001 per share 80,000 $4.01 $320,800
Option
Options to purchase common stock 80,000 $4.01 $320,800
Sale
Common stock, par value $0.001 per share 80,000 $16.16 $1,292,800
Option
Common Stock, par value $0.001 per share 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common Stock, par value $0.001 per share 9,000 N/A N/A
Option
Restricted Stock Units 9,000 N/A N/A
Option
Common stock, par value $0.001 per share 50,000 $1.13 $56,500
Sale
Common stock, par value $0.001 per share 50,000 $14.02 $701,000
Option
Options to purchase common stock 50,000 $1.13 $56,500
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common Stock, par value $0.001 per share 10,000 N/A N/A
Option
Common stock, par value $0.001 per share 14,667 N/A N/A
Sale
Common stock, par value $0.001 per share 5,918 $16.85 $99,718
Option
Restricted Stock Units 14,667 N/A N/A
Option
Common stock, par value $0.001 per share 88,000 $4.64 $408,320
Option
Options to purchase common stock 88,000 $4.64 $408,320
Sale
Common stock, par value $0.001 per share 88,000 $15.69 $1,380,544
Option
Options to purchase common stock 55,000 $4.01 $220,550
Option
Common stock, par value $0.001 per share 55,000 $4.01 $220,550
Sale
Common stock, par value $0.001 per share 6,152 $6.61 $40,646
Option
Common stock, par value $0.001 per share 6,152 $4.13 $25,408
Option
Options to purchase common stock 6,152 $4.13 $25,408
Option
Options to purchase common stock 143,848 $4.13 $594,092
Option
Common stock, par value $0.001 per share 143,848 $4.13 $594,092
Sale
Common stock, par value $0.001 per share 143,848 $6.6 $948,678
Sale
Common stock, par value $0.001 per share 3,612 $6.99 $25,237
Option
Common stock, par value $0.001 per share 14,667 N/A N/A
Option
Restricted Stock Units 14,667 N/A N/A
Option
Restricted Stock Units 14,666 N/A N/A
Option
Common stock, par value $0.001 per share 14,666 N/A N/A
Sale
Common stock, par value $0.001 per share 3,668 $3.45 $12,644
Sale
Common stock, par value $0.001 per share 150,000 $2.53 $379,500
Option
Options to purchase common stock 150,000 $2.53 $379,500
Option
Common stock, par value $0.001 per share 150,000 $2.53 $379,500
Sale
Common stock, par value $0.001 per share 100,000 $1.13 $113,000
Option
Options to purchase common stock 100,000 $1.13 $113,000
Option
Common stock, par value $0.001 per share 100,000 $1.13 $113,000
Sale
Common stock, par value $0.001 per share 100,000 $0.79 $79,000
Option
Options to purchase common stock 100,000 $0.79 $79,000
Option
Common stock, par value $0.001 per share 100,000 $0.79 $79,000

Catalyst Pharmaceuticals key executives

Catalyst Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: